# Tygacil

NDC: 0008-4990
Generic name: TIGECYCLINE
Labeler / Manufacturer: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20080615

FDA application: NDA021821

## Active ingredients

- TIGECYCLINE: 50 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0008-4990"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0008-4990
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2ccdb48e-c14a-4eeb-348c-4920ccfd7465